Who Paid My Doc
Neuraceq
Drug Diagnostic Tracer
NDC 54828-001-30
General payments
$74,428
Research payments
$918,825
Through program year 2025, $74,428 in general payments and $918,825 in research payments were reported against Neuraceq (Diagnostic Tracer).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $51,321 | 671 |
| 2025 | Research | $481,650 | 1 |
| 2024 | General | $8,047 | 353 |
| 2024 | Research | $243,675 | 1 |
| 2023 | General | $5,006 | 203 |
| 2023 | Research | $28,500 | 1 |
| 2022 | General | $2,249 | 78 |
| 2022 | Research | $165,000 | 1 |
| 2021 | General | $1,033 | 51 |
| 2020 | General | $395 | 21 |
| 2019 | General | $6,377 | 63 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,440 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.